TORONTO, ONTARIO - Oct. 6, 2017 - Maricann Group Inc. has partnered with Julian Marley and International Cannabrands Ltd., a wholly owned subsidiary of GEA Technologies Ltd., to cultivate and formulate JuJu Royal, a premium and market established group of products. Julian, son of the iconic Bob Marley, is a true and authentic representation of Rasta culture. A world renowned reggae artist and devoted Rastafarian, Julian conveys his message of legalization, freedom and love through his music, and the JuJu Royal brand, according to a press release.
"We're committed to producing all natural cannabis, marrying our vision for 'A World of Good' with Julian Marley to deliver a curated and unique experience to our patients, and soon, the broader market," Ben Ward, CEO of Maricann said. "JuJu Royal is an exclusive line of products currently offered in California and Colorado with carefully selected genetics, combined with solvent free extraction, delivering high-quality cannabis. We're thrilled to offer this unique and quality differentiated experience to Canadians and Europeans (where legal)."
Maricann will offer the premium JuJu Royal line to its existing medical patients starting on Jan. 1, with four of Julian's designer strains of dry flower available for purchase.
"Maricann is exactly the type of strategic partner we are looking for," stated Jeffrey Britz, Chairman and CEO of International Cannabrands. "Their core value of quality and commitment to the wellness of their customers aligns exactly with ours. They currently serve thousands of patients in Canada and have a vision to develop cannabis markets worldwide. We believe Maricann is uniquely positioned to capitalize on the adult-use cannabis market in Canada and are excited they have chosen us."
Julian Marley added, "JuJu Royal is freedom. I welcome Maricann to JuJu Royal. Our vision is to heal the world with organics, as herb is the healing of the nation. It's a pleasure to spread this love and joy together all because of this amazing plant."
Under the terms of the agreement, subject to meeting certain revenue targets, Maricann will have the exclusive right to cultivate, extract and distribute in Canada the JuJu Royal line of products that are currently offered in the United States. The agreement is for a period of three years, following receipt of approval from Health Canada to sell the products. In addition, Maricann has a right of first refusal to distribute any JuJu Royal products in Europe.
